Establishment and Characterization of a Functionally Competent Type 2 Conventional Dendritic Cell Line

Matteo Pigni,Devika Ashok,Mathias Stevanin,Hans Acha-Orbea
DOI: https://doi.org/10.3389/fimmu.2018.01912
IF: 7.3
2018-08-24
Frontiers in Immunology
Abstract:Dendritic cells (DCs) are the most potent antigen presenting cells and possess an incomparable ability to activate and instruct T cells, which makes them one of the cornerstones in the regulation of the cross-talk between innate and adaptive immunity. Therefore, a deep understanding of DC biology lays the foundations to describe and to harness the mechanisms that regulate the development of the adaptive response, with clear implications in a vast array of fields such as the study of autoimmune diseases and the development of new vaccines. However, the great difficulty to obtain large quantities of viable non-activated DCs for experimentation have considerably hindered the progress of DC research. Several strategies have been proposed to overcome these limitations by promoting an increase of DC abundance <i>in vivo</i>, by inducing DC development from DC progenitors <i>in vitro</i> and by generating stable DC lines. In the past years, we have described a method to derive immortalized stable DC lines, named MutuDCs, from the spleens of Mushi1 mice, a transgenic mouse strain that express the simian virus 40 Large T-oncogene in the DCs. The comparison of these DC lines with the vast variety of DC subsets described <i>in vivo</i> has shown that all the MutuDC lines that we have generated so far have phenotypic and functional features of type 1 conventional DCs (cDC1s). With the purpose of deriving DC lines with characteristics of type 2 conventional DCs (cDC2s), we bred a new Batf3<sup>-/-</sup> Mushi1 murine line in which the development of the cDC1 subset is severely defective. The new MutuDC line that we generated from Batf3<sup>-/-</sup> Mushi1 mice was phenotypically and functionally characterized in this work. Our results demonstrated that all the tested characteristics of this new cell line, including the expression of subset-determining transcription factors, the profile of cytokine production and the ability to present antigens, are comparable with the features of splenic CD4<sup>-</sup> cDC2s. Therefore, we concluded that our new cell line, that we named CD4<sup>-</sup> MutuDC2 line, represents a valuable model for the CD4<sup>-</sup> cDC2 subset.
immunology
What problem does this paper attempt to address?